In the present review, we’ll focus on the available data regarding the expression of PD-L1 and PD-L2 in thyroid cancer tissues and its possible clinical implications in terms of prognosis and therapy for the most aggressive thyroid cancers. Here, PDCD1LG2 is linked to thyroid gland carcinoma.